Literature DB >> 18663575

Surgical management of gastroesophageal reflux disease in obesity.

Sayeed Ikramuddin1.   

Abstract

Bariatric surgery is ubiquitous today. In the obese patient with comorbid gastroesophageal reflux disease (GERD), it is increasingly being used as an alternative to fundoplication because it not only has an effect on GERD but also on other comorbid illnesses. Traditional GERD surgery is designed to augment the mechanical barriers against reflux, decrease acid production in the stomach, improve gastric emptying, or divert bile from the stomach. Roux-en-Y gastric bypass addresses these issues in addition to resulting in profound weight loss in patients. Banding may have a positive influence in patients' GERD, though to a lesser extent. The duodenal switch provides excellent control for patients with alkaline reflux. A revision of the 1991 National Institutes of Health guidelines for determining bariatric surgical candidates is overdue, and it may be feasible to consider expanding the body mass index and comorbidity requirements to reflect the benefits offered by these techniques for GERD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18663575     DOI: 10.1007/s10620-008-0415-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

Review 1.  Laparoscopic gastric bypass surgery: outcomes.

Authors:  Benjamin E Schneider; Leonardo Villegas; George L Blackburn; Edward C Mun; Jonathan F Critchlow; Daniel B Jones
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2003-08       Impact factor: 1.878

2.  Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.

Authors:  L Lundell; P Miettinen; H E Myrvold; J G Hatlebakk; L Wallin; A Malm; I Sutherland; A Walan
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

3.  Open and laparoscopic Roux-en-Y gastric bypass: our techniques.

Authors:  Sayeed Ikramuddin; Michael L Kendrick; Todd A Kellogg; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

Review 4.  Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.

Authors:  Garth H Ballantyne
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

5.  Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients.

Authors:  C D Mercer; S F Wren; L R DaCosta; I T Beck
Journal:  J Med       Date:  1987

6.  Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux.

Authors:  T R DeMeester; K H Fuchs; C S Ball; M Albertucci; T C Smyrk; J N Marcus
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

7.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

8.  Despite high satisfaction, majority of gastro-oesophageal reflux disease patients continue to use proton pump inhibitors after antireflux surgery.

Authors:  A Madan; A Minocha
Journal:  Aliment Pharmacol Ther       Date:  2006-03-01       Impact factor: 8.171

9.  Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn.

Authors:  E J Patterson; D G Davis; Y Khajanchee; L L Swanström
Journal:  Surg Endosc       Date:  2003-07-21       Impact factor: 4.584

10.  Complications and antireflux medication use after antireflux surgery.

Authors:  Jason A Dominitz; Christopher A Dire; Kevin G Billingsley; Jeffrey A Todd-Stenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  4 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

3.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 4.  The Effect of Bariatric Surgery and Endoscopic Procedures on Gastroesophageal Reflux Disease.

Authors:  Ofer Z Fass; Hiroshi Mashimo
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.